Overview

124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome

Status:
ENROLLING_BY_INVITATION

Trial end date:
2027-05-01

Target enrollment:

Participant gender:

Summary

This clinical trial will use the amyloid-binding radiotracer, 124I-evuzamitide, to potentially detect amyloid, in the heart and elsewhere, in patients who have a history of lumbar spinal stenosis and/or carpal tunnel syndrome.

Phase:

PHASE2

Details

Lead Sponsor:

University of Tennessee Graduate School of Medicine

Collaborator:

Attralus, Inc.